0001415889-24-004210.txt : 20240216 0001415889-24-004210.hdr.sgml : 20240216 20240216180355 ACCESSION NUMBER: 0001415889-24-004210 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240214 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lettmann Jason CENTRAL INDEX KEY: 0001688269 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39386 FILM NUMBER: 24649910 MAIL ADDRESS: STREET 1: C/O RA PHARMACEUTICALS, INC. STREET 2: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form4-02162024_110246.xml X0508 4 2024-02-14 0001810182 ALX ONCOLOGY HOLDINGS INC ALXO 0001688269 Lettmann Jason C/O ALX ONCOLOGY HOLDINGS INC. 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 true true false false CHIEF EXECUTIVE OFFICER 0 Common Stock 2024-02-14 4 A 0 60000 0 A 167220 D Employee Stock Option 15.84 2024-02-14 4 A 0 190000 0 A 2034-02-13 Common Stock 190000 190000 D The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024. Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024. /s/ Peter Garcia, by power of attorney 2024-02-16